These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34481024)

  • 1. Engineering a "three-in-one" hirudin prodrug to reduce bleeding risk: A proof-of-concept study.
    Zhu Y; Han HH; Zhai L; Yan Y; Liu X; Wang Y; Lei L; Wang JC
    J Control Release; 2021 Oct; 338():462-471. PubMed ID: 34481024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving long circulation and procoagulant platelet targeting by engineering of hirudin prodrug.
    Han HH; Zhang HT; Wang R; Yan Y; Liu X; Wang Y; Zhu Y; Wang JC
    Int J Pharm; 2020 Nov; 589():119869. PubMed ID: 32919000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating prodrug characteristics of a novel anticoagulant fusion protein neorudin, a prodrug targeting release of hirudin variant 2-Lys47 at the thrombosis site, by means of in vitro pharmacokinetics.
    Dong X; Gu R; Zhu X; Gan H; Liu J; Jin J; Meng Z; Dou G
    Eur J Pharm Sci; 2018 Aug; 121():166-177. PubMed ID: 29802897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.
    Song Y; Bienvenu LA; Bongcaron V; Prijaya SA; Maluenda AC; Walsh APG; McFayden JD; Pietersz GA; Peter K; Wang X
    Theranostics; 2024; 14(8):3267-3281. PubMed ID: 38855181
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
    Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss.
    Sheffield WP; Eltringham-Smith LJ; Bhakta V
    BMC Biotechnol; 2018 Apr; 18(1):21. PubMed ID: 29621998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ formed depot of elastin-like polypeptide-hirudin fusion protein for long-acting antithrombotic therapy.
    Tian X; Feng M; Wei X; Cheng C; He K; Jiang T; He B; Gu Z
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2314349121. PubMed ID: 38442174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two characteristics of a recombinant fusion protein composed of staphylokinase and hirudin: high thrombus affinity and thrombus-targeting release ofanticoagulant activity.
    Yu A; Zhang C; Dong C; Yu H; Zhong G; Wang L; Wu C
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1955-61. PubMed ID: 19256345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic and anticoagulant effects of a recombinant staphylokinase-hirudin fusion protein.
    Ren K; Gong H; Huang J; Liu Y; Dong Q; He K; Tian L; Zhang F; Yu A; Wu C
    Thromb Res; 2021 Dec; 208():26-34. PubMed ID: 34688099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits.
    Lu WF; Mo W; Liu Z; Fu WG; Guo DQ; Wang YQ; Song HY
    Thromb Res; 2010 Oct; 126(4):e339-43. PubMed ID: 20483158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-Covered Nanocarriers for Targeted Delivery of Hirudin to Eliminate Thrombotic Complication in Tumor Therapy.
    Zhang K; Ma Z; Li S; Zhang W; Foda MF; Zhao Y; Han H
    ACS Nano; 2022 Nov; 16(11):18483-18496. PubMed ID: 36350264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antithrombotic Effect of Recombinant Neorudin on Thrombi.
    Liu YB; Zhang L; Zhou XC; Zhou Y; Liu Y; Zheng C; Xu X; Geng PP; Hao CH; Zhao ZY; Wu CT; Jin JD
    Drug Des Devel Ther; 2022; 16():1667-1678. PubMed ID: 35677424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally activity-released bifunctional fusion protein enhances antithrombosis and alleviates bleeding risk.
    Shi B; Yu A; Liu Y; Li J; Jin J; Dong C; Wu C
    J Thromb Thrombolysis; 2007 Dec; 24(3):283-92. PubMed ID: 17487572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new antithrombotic agents].
    Meyer Samama M
    Presse Med; 2005 Oct; 34(18):1309-14. PubMed ID: 16269995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.
    Meyer BJ; Fernández-Ortiz A; Mailhac A; Falk E; Badimon L; Michael AD; Chesebro JH; Fuster V; Badimon JJ
    Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition.
    Mo W; Zhang YL; Chen HS; Wang LS; Song HY
    J Thromb Thrombolysis; 2009 Aug; 28(2):230-7. PubMed ID: 18998199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model.
    Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.